<div id="readability-page-1"><p>Empowered Funds LLC lifted its stake in  Lam Research Corporation (NASDAQ:LRCX - Free Report) by 39.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 261,016 shares of the semiconductor company's stock after acquiring an additional 73,544 shares during the quarter. Empowered Funds LLC's holdings in Lam Research were worth $25,407,000 at the end of the most recent reporting period.</p><ul><li>MarketBeat Week in Review – 11/10 - 11/14</li></ul><p>Several other institutional investors have also recently added to or reduced their stakes in LRCX. Brighton Jones LLC boosted its position in shares of  Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock worth $1,025,000 after buying an additional 12,936 shares during the period.  Mutual of America Capital Management LLC purchased a new position in  Lam Research during the 1st quarter valued at about $13,345,000.  Edgestream Partners L.P. grew its position in  Lam Research by 29.0% in the 1st quarter. Edgestream Partners L.P. now owns 4,168 shares of the semiconductor company's stock valued at $303,000 after acquiring an additional 938 shares in the last quarter.  Private Advisor Group LLC grew its position in  Lam Research by 10.3% in the 1st quarter. Private Advisor Group LLC now owns 60,701 shares of the semiconductor company's stock valued at $4,413,000 after acquiring an additional 5,664 shares in the last quarter.  Finally, OneAscent Financial Services LLC purchased a new stake in  Lam Research during the first quarter worth about $500,000. Institutional investors and hedge funds own  84.61% of the company's stock. </p><h2>Lam Research Price Performance</h2><p>Lam Research stock opened at $147.46 on Tuesday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The company has a fifty day simple moving average of $141.60 and a 200-day simple moving average of $110.47. The stock has a market cap of $185.21 billion, a P/E ratio of 32.48, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $167.15. </p><ul><li>2 Reasons to Buy Into Lam’s 185% Rally, 1 Reason to Run Away</li></ul><p>Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.Lam Research's quarterly revenue was up 27.7% on a year-over-year basis. During the same period last year, the firm earned $0.86 earnings per share.  Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts expect that  Lam Research Corporation will post 3.71 EPS for the current fiscal year. </p><h2>Lam Research Dividend Announcement</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research's payout ratio is presently 22.91%. </p><h2>Insiders Place Their Bets</h2><ul><li>High-Flyers Near Resistance: 3 Stocks to Watch for a Dip</li></ul><p>In related news, CFO Douglas R. Bettinger sold 40,080 shares of the business's stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares of the company's stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the sale, the insider directly owned 56,786 shares of the company's stock, valued at $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is owned by company insiders. </p><h2>Analysts Set New Price Targets</h2><p>Several research analysts have recently commented on LRCX shares. Susquehanna raised their price objective on shares of Lam Research from $135.00 to $200.00 and gave the company a &#34;positive&#34; rating in a research note on Thursday, October 23rd. Wells Fargo &amp; Company increased their target price on shares of Lam Research from $135.00 to $145.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, October 23rd. Raymond James Financial boosted their price target on shares of Lam Research from $90.00 to $110.00 and gave the stock an &#34;outperform&#34; rating in a research note on Thursday, July 31st. Hsbc Global Res raised Lam Research to a &#34;hold&#34; rating in a research report on Tuesday, September 30th. Finally, Berenberg Bank lifted their target price on Lam Research from $122.00 to $165.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 23rd. One investment analyst  has rated the stock with a Strong Buy rating, twenty-six have issued  a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock  has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $149.04.</p><p><b>View Our Latest Stock Report on LRCX</b></p><h2>Lam Research Profile</h2> (Free Report)<p>Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.</p><h2>See Also</h2><ul><li>Five stocks we like better than Lam Research</li><li>How to Calculate Options Profits</li><li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li><li>Find and Profitably Trade Stocks at 52-Week Lows</li><li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li><li>Investing In Preferred Stock vs. Common Stock</li><li>How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lam Research Right Now?</h2><p>Before you consider Lam Research, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LRCX

<p>Empowered Funds LLC increased its stake in Lam Research Corporation by 39.2% in Q2, owning 261,016 shares valued at $25.4 million. Other institutional investors also adjusted their positions in Lam Research. The company reported strong quarterly earnings, with a 27.7% revenue increase year-over-year. Lam Research announced a quarterly dividend of $0.26 per share. Recent insider sales were disclosed, with CFO Douglas Bettinger and insider Ava Harter selling shares. Analysts have set new price targets for the stock.</p>

Empowered Funds LLC Grows Holdings in Lam Research Corporation $LRCX